| 776b7816-9ef0-4872-9266-8e3b39940714 | d27a2eb7-ed35-4ef4-a14f-279f202c9249 | 0092124 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5a1a725e-b2e4-4949-98d3-f6cd03b75b57 | 42c14584-daee-47d8-974c-e167c3263f9f | 0092125 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 80af925e-af45-4209-b4ab-566b16cf128f | b06342b9-0413-4458-a21d-a7eb1fa5e945 | 0092126 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6bf745e4-661f-494e-a7db-a0d8d27df33a | b06342b9-0413-4458-a21d-a7eb1fa5e945 | 0092127 | NARCOSE DE CRIANÇA (POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| dc463939-ce68-421b-b654-cdff0b709415 | df70dd45-6366-41bd-8028-d7f3a476bf04 | 0092128 | NARCOSE PARA BRAQUITERAPIA DE ALTA DOSE ( POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 519343a7-014d-46c6-ba3f-b78551e85747 | <span class="null">NULL</span> | 0092129 | NARCOSE PARA BRAQUITERAPIA DE ALTA DOSE (POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5e3973de-6ffa-436f-87e0-e9978ddb6961 | 9368fdb1-1146-44d9-ac55-faaa21b921b4 | 0092130 | NEOPLASIA OVARIANA DE CELULAS GERMINATIVAS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1b206467-097a-45ac-83f7-62ffd989367c | 5093ddae-e405-444a-8aa8-9a5af6ff52bb | 0092131 | NEOPLASIA DE CELULAS GERMINATIVAS DE OVARIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ef53805c-747f-4a36-ab8b-958b3d7acd21 | 1af94c2e-1b96-41c1-a3be-12ad83275e0f | 0092132 | NEOPLASIA DE CELULAS GERMINATIVAS EXTRA-GONADAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c23456fc-6d2c-48bb-b217-b40c77caac7a | 4d4ced5b-0036-4680-9dc0-305df74c56bb | 0092133 | NEOPLASIA DE CELULAS PLASMATICAS 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9eec579e-f368-4ea9-985b-daf885fcf701 | 697bef2e-0773-45a6-ba82-8527120334ba | 0092134 | NEOPLASIA MALIGNA EPITELIAL DE CABECA E PESCOCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3f8edd3a-49af-48e2-8459-11a09276cff4 | 973a7e3c-aeb4-4e2d-af98-8fc55ccf55d0 | 0092135 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 2A | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3a97353d-1ae6-415d-84f7-1cad5b711f36 | 29ded6ca-1b0e-4db0-9500-6667aa655ba3 | 0092136 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 1A L | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 970bfdb8-fb8d-4eda-ad96-cc7b52fee7bf | <span class="null">NULL</span> | 0092137 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO IV OU RECIDIV | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ee8e3db2-fa23-4857-90fd-05002bb9b485 | ad85e0c9-2e6a-450d-9cf4-259b400951d3 | 0092138 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIOS IA E IB/G3, | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1de6208f-4057-4c93-845e-713b38cfe988 | c865cea4-c4ee-494a-ba1f-1091be8f59fb | 0092139 | NEOPLASIA TROFOBLASTICA GESTACIONAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| febd8193-638d-460a-b86f-ff0dcf953822 | b93e4c5a-89a4-40b3-a608-53d94994cee1 | 0092140 | NEOPLASIA TROFOBLASTICA GESTACIONAL (CORIOCARCINOMA DE RISCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5cbbb0ea-0711-4b6b-b713-a535d1280d30 | 265c2660-55fd-4a6a-88a9-13be6e56b9a6 | 0092141 | NEOPLASIA TROFOBLASTICA GESTACIONAL(CORIOCARCINOMA DE RISCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e8f27cd6-41e3-4fd2-b5ce-c9d2387d0af4 | 691c7610-3aea-4fde-b260-ab1d73c34af4 | 0092142 | OSTEOSSARCOMA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 601a71f6-ec7a-4c30-810c-c21d7f3df92d | <span class="null">NULL</span> | 0092143 | OSTEOSSARCOMA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 66b946bb-9d4e-4643-836f-9134ecbda428 | <span class="null">NULL</span> | 0092145 | PLANEJAMENTO COMPLEXO ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6a22e863-8263-4cdd-8bb8-b66fc4e318d5 | <span class="null">NULL</span> | 0092146 | PLANEJAMENTO DE BRAQUITERAPIA DE ALTA TAXA DE DOSE ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f38a3401-caeb-4e0b-87fe-ef2730792dc1 | 27f04c69-b437-4ef7-b888-6da058cfa58e | 0092147 | PLANEJAMENTO SIMPLES (POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1f8003d3-da4a-408f-9d4f-edf27a7b97c1 | c78a7197-96c8-4e27-8aa1-c913f18a121b | 0092148 | PLANEJAMENTO TRIDIMENSIONAL ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 197590b2-2ec5-4cf2-b279-a32149a8ab8f | 2ab15622-636a-4c08-9b0b-f223e86d43a4 | 0092149 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO I (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7fdd7974-b23b-407e-b052-b857b1dc28f1 | 65e21349-3d1e-49ae-8b6a-56554e1abcce | 0092150 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO II (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7b75741a-6e02-4f8b-95dd-a16a712db46b | 27f04c69-b437-4ef7-b888-6da058cfa58e | 0092151 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7b26dc72-d489-418a-a846-844be660c35d | c78a7197-96c8-4e27-8aa1-c913f18a121b | 0092152 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO III (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bf7a91d7-b584-46b2-91bf-31e0358ab3eb | 65e21349-3d1e-49ae-8b6a-56554e1abcce | 0092153 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1179515c-c631-4995-af9c-8bdeae129c83 | f88d9432-84c2-4a6b-8577-8b4313e11d7b | 0092154 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c0b19795-7dfb-4536-b15b-eac50c146ccf | 084ad618-70d0-4c91-b2a1-2d01e7bfbb31 | 0092155 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7da9fcae-1108-48c5-8dbf-8eefd26f3b24 | 368901d1-5c4e-4f53-ac36-9f798eaadf65 | 0092156 | QUIMIOTERAPIA DE CARCINOMA DO FIGADO OU DO TRATO BILIAR AVANCADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 71dd2dc3-fb52-476c-a555-a6a694928792 | 7e3dfa08-9c1b-4b7c-bccd-f20043f24507 | 0092157 | QUIMIOTERAPIA DE CARCINOMA EPIDERMOIDE/ADENOCARCINOMA DE ESOFAGO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fd2a3a5c-213d-4f93-8705-97c612bc3867 | 58a4156f-8001-4bc8-aedb-1c4cb986d8f7 | 0092158 | QUIMIOTERAPIA DE CARCINOMA UROTELIAL AVANCADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 702842b8-85b9-495c-8472-1a939d246ee5 | be482f23-4373-4771-855e-66e5708e536b | 0092159 | QUIMIOTERAPIA DE LEUCEMIA MIELOIDE CRONICA EM FASE CRONICA - MARCADOR POSITIVO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 89f6d987-892b-4bd3-bede-187e9b5a5d07 | 33a33de2-d09d-4c3f-8d7d-5f7f3e4af214 | 0092160 | QUIMIOTERAPIA DE LINFOMA DIFUSO DE GRANDES CELULAS B 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 26bd9a74-35ad-4080-a2d8-460b4a1170a6 | 5c9280db-490d-4adc-be62-ec67a5efa2e0 | 0092161 | QUIMIOTERAPIA DE NEOPLASIA DE CELULAS PLASMATICAS - 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bc2c60f5-0f70-4a2b-a42c-3aff7b30e8e8 | e32e3391-9d32-42a4-a638-67f12ff0976a | 0092162 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA DO TIMO AVANÇADA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b5492887-eb36-47e4-bdb4-02c0dfce10d2 | 5ded7081-d3f6-4268-ad8e-d11434924809 | 0092163 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTOMAGO (POS OPERATORIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cb2ee478-7a51-40f9-a7b4-2867407ce568 | 28e918aa-abec-499b-b0dd-8928171492d4 | 0092164 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTOMAGO (PRE-OPERATORIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 451cc19c-d7a6-4819-b0c5-e03514077a94 | 298bf386-0628-4208-b663-aa6d80975ec0 | 0092165 | QUIMIOTERAPIA DO ADENOCARCINOMA DE RETO (ESTADIOS II E III OU DUKES B E C) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 66663dd5-528d-4ff0-8197-944efb439102 | 315c8f8d-6f2d-418e-8db1-9c79998c14c9 | 0092166 | QUIMIOTERAPIA DO CARCINOMA DE MAMA (PRÉVIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 8d47b942-4f60-49fa-9cae-bd632e9bafa2 | 3666cdd4-0766-496a-9d06-c8c61bb8a6ba | 0092167 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 254a542a-29e9-4bc9-a8a1-f34b64894bfd | 5891323f-bb3c-4765-935d-a0aa190e441c | 0092168 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO -1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 02747431-424b-4fd6-a9bd-0512d3d2a79c | 578cad79-f4c0-4f44-90d1-cbd9880117e8 | 0092169 | QUIMIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 10a845c0-70b4-40ea-b8ae-97b0ce3256ea | 35c21071-3106-49f5-9f7a-a4c164682dbc | 0092170 | QUIMIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7c037f3e-87a5-4f7d-a2b5-74a26bb881e3 | a45c615d-06a8-477e-a1c7-f74b3d0a5080 | 0092171 | QUIMIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 48b407a8-4eb1-440a-9eb5-2501179c39ef | <span class="null">NULL</span> | 0092172 | QUIMIOTERAPIA INTRA-TECAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cc593823-c2c2-4e99-a07b-c5745c6a335d | <span class="null">NULL</span> | 0092173 | QUIMIOTERAPIA INTRA-VESICAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 87981135-b849-4f8b-b3b7-ebb482278e6b | <span class="null">NULL</span> | 0092174 | RADIOCIRURGIA UM ISOCENTRO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |